Phase 4 Uveitis Trial, Not Yet Recruiting NCT05105347 Sponsor: Peking Union Medical College Hospital Condition: Uveitis
Back to Uveitis

Phase 4 Uveitis Trial, Not Yet Recruiting

NCT05105347
Not Yet Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Behçet's disease (a rare inflammatory condition) that meets specific international diagnostic criteria from 2013, and you have recently had a flare-up of severe eye inflammation affecting the back or all layers of the eye.
  • You are currently taking at least 10mg per day of prednisone (a steroid) or a similar medication at an equivalent dose.

Who may not be able to join:

  • You have been treated with a type of medication called a TNF-alpha inhibitor (a specific kind of immune-suppressing drug) within the last 3 months.
  • You are currently pregnant or breastfeeding.
  • You have or have had cancer.
  • You have heart failure.
  • You have a condition affecting the protective covering of your nerves (such as multiple sclerosis) (confirm with trial site).
  • You have kidney problems, shown by a specific blood test result being above a certain level.
  • You have depression or another mental health condition.
  • You have a history of inflammatory joint disease or other autoimmune conditions.
  • You have severe Behçet's disease symptoms in other parts of your body beyond mouth/genital sores or skin involvement.
  • You have received an organ or bone marrow transplant, or have severe heart failure at a specific medical grade.
  • You have active liver disease shown by abnormal liver blood test results.
  • Your white blood cell count is below a certain level on a blood test.
  • Your platelet count (cells that help blood clot) is below a certain level.
  • Your haemoglobin level (a measure of red blood cells) is below a certain level.
  • A specific test for tuberculosis (TB) shows a result above a certain threshold.
  • You have an active stomach ulcer, an ongoing infection, significant bone thinning (osteoporosis), or other reasons why taking moderate-dose steroids would not be safe for you.
  • You have other serious eye diseases, or you have had eye surgery within the last 3 months.
  • There is cloudiness or obstruction in your eye that prevents a clear view of the back of the eye.
  • You have tested positive for Hepatitis B, Hepatitis C, HIV, or syphilis.
  • You weigh less than 45 kg (approximately 99 lbs).
  • You have issues with alcohol or drug misuse.
  • You have a condition affecting your mental or cognitive abilities.
  • You are considered unlikely to be able to follow the trial's requirements (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: +8615600612346

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
10 November 2021
Est. completion
31 December 2026

Primary endpoints

Uveitis control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov